Global
  • Company
  • Expertise
  • Research
  • Careers
  • Investors
Global
EN
Back
Company
Back
Expertise

Healthcare

Life Science

Performance Materials

Back
Research
Back
Careers
Back
Investors

Updated Digital Version of Periodic Table of the Elements

Darmstadt, Germany, January 4, 2016 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced today that it has relaunched its PTE app, a free interactive periodic table of the...

04 Jan 2016 | Darmstadt, Germany
  • Interactive periodic table of the elements (PTE) relaunched after 1 million downloads
  • Expanded data sets, smoother navigation and simpler user interface make experimenting offline attractive

Darmstadt, Germany, January 4, 2016 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced today that it has relaunched its PTE app, a free interactive periodic table of the elements. After more than one million downloads of the previous version, an update is now available that has been improved based on user feedback. 

As a company that stands for innovation, we are making the periodic system, one of the building blocks of science, comprehensible to everyone and accessible to curious explorers.

With a new design, more functions and improved features, the new app is now even better suited to user needs. Apart from the periodic system, which allows digital and interactive research, it offers features such as information on the individual elements, visualized element properties, well as a molar mass calculator. It is available in four languages via an improved interactive user interface. In addition, the contents of the app are now also available offline. The user-friendlier app has been modified to include more data sets, easier navigation as well as the elements 113-118. The data sets can now be updated separately from the app.

With its PTE app, Merck KGaA, Darmstadt, Germany, is providing an interactive and free tool for people interested in chemistry. The PTE app invites everyone, whether school students or professors, laypeople or professional technicians, to experiment. The user experience has been considerably enhanced by more information on the elements, visualization and interactive features.

The app can be downloaded onto iOS devices here, or Android devices here.

More information is available here.

Downloads

For more information, contact Neetha Mahadevan
+49 6151 72-6328

All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.

Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck KGaA, Darmstadt, Germany, generated sales of € 12.85 billion in 66 countries.

Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the „Merck” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Related News

Press Releases

Merck KGaA, Darmstadt, Germany, Presents Updated Results for Bifunctional Immunotherapy ...

Merck KGaA, Darmstadt, Germany today announced new and updated results from expansion cohorts of two ongoing M7824 Phase I clinical trials at the ESMO 2018 Congress in Munich, October.

2018/10/22

Cookie Disclaimer

This website uses 'cookies' to give you the best, most relevant experience. Using this website means you’re OK with this. You can change which cookies are set at any time - and find out more about them in our cookie policy. Cookie Policy

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement.